Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)

Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease, therefore stratification of patients is essential to predict their responses to therapies and to choose the best treatment. PDAC-derived organoids were produced from PDTX and Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Bian, Benjamin, Juiz, Natalia Anahi, Gayet, Odile, Bigonnet, Martin, Brandone, Nicolas, Roques, Julie, Cros, Jérôme, Wang, Nenghui, Dusetti, Nelson, Iovanna, Juan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560163/
https://ncbi.nlm.nih.gov/pubmed/31231611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00475
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge